Pharmaceutical glassmaker Bormioli Pharma wants to invest in its San Vito al Tagliamento, Italy factory.
The group plans to invest €22 million with the aim of increasing turnover from €20 million to €28 million.
Work will start in August 2019 and reach full capacity by 2021.
The plant may stop prodction of glass tubes and manufacture hollow glass instead.
The number of employees at the plant will rise from 80 to 125.
Bormioli Pharma was established at the end of 2017 after it was transferred by the Bormioli Rocco group.
It is today owned by the Triton Capital Investment Fund.
